vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and JBT Marel Corp (JBTM). Click either name above to swap in a different company.

Alignment Healthcare, Inc. is the larger business by last-quarter revenue ($1.0B vs $1.0B, roughly 1.0× JBT Marel Corp). JBT Marel Corp runs the higher net margin — 5.3% vs -1.1%, a 6.4% gap on every dollar of revenue. On growth, JBT Marel Corp posted the faster year-over-year revenue change (115.6% vs 44.4%). JBT Marel Corp produced more free cash flow last quarter ($83.5M vs $-55.4M). Over the past eight quarters, JBT Marel Corp's revenue compounded faster (60.3% CAGR vs 26.9%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

JBT Marel Corporation, formerly known as JBT Corporation, or John Bean Technologies Corporation, is a food processing machinery and automated vehicle company. The company was incorporated in 2008 when FMC Technologies divested its non-energy businesses. The company is based in Chicago, Illinois and traces its history back to a company founded in 1884 by John Bean, an orchardist in Los Gatos, California.

ALHC vs JBTM — Head-to-Head

Bigger by revenue
ALHC
ALHC
1.0× larger
ALHC
$1.0B
$1.0B
JBTM
Growing faster (revenue YoY)
JBTM
JBTM
+71.1% gap
JBTM
115.6%
44.4%
ALHC
Higher net margin
JBTM
JBTM
6.4% more per $
JBTM
5.3%
-1.1%
ALHC
More free cash flow
JBTM
JBTM
$138.9M more FCF
JBTM
$83.5M
$-55.4M
ALHC
Faster 2-yr revenue CAGR
JBTM
JBTM
Annualised
JBTM
60.3%
26.9%
ALHC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ALHC
ALHC
JBTM
JBTM
Revenue
$1.0B
$1.0B
Net Profit
$-11.0M
$53.1M
Gross Margin
34.5%
Operating Margin
-1.0%
7.2%
Net Margin
-1.1%
5.3%
Revenue YoY
44.4%
115.6%
Net Profit YoY
64.6%
858.6%
EPS (diluted)
$-0.04
$1.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
JBTM
JBTM
Q4 25
$1.0B
$1.0B
Q3 25
$993.7M
$1.0B
Q2 25
$1.0B
$934.8M
Q1 25
$926.9M
$854.1M
Q4 24
$701.2M
$467.6M
Q3 24
$692.4M
$453.8M
Q2 24
$681.3M
$402.3M
Q1 24
$628.6M
$392.3M
Net Profit
ALHC
ALHC
JBTM
JBTM
Q4 25
$-11.0M
$53.1M
Q3 25
$3.7M
$66.0M
Q2 25
$15.7M
$3.4M
Q1 25
$-9.1M
$-173.0M
Q4 24
$-31.1M
$-7.0M
Q3 24
$-26.4M
$38.9M
Q2 24
$-24.0M
$30.7M
Q1 24
$-46.5M
$22.8M
Gross Margin
ALHC
ALHC
JBTM
JBTM
Q4 25
34.5%
Q3 25
35.9%
Q2 25
35.8%
Q1 25
34.2%
Q4 24
38.4%
Q3 24
36.1%
Q2 24
35.6%
Q1 24
35.8%
Operating Margin
ALHC
ALHC
JBTM
JBTM
Q4 25
-1.0%
7.2%
Q3 25
0.8%
10.2%
Q2 25
2.2%
5.2%
Q1 25
-0.6%
-3.9%
Q4 24
-3.2%
3.4%
Q3 24
-2.8%
10.3%
Q2 24
-2.7%
6.7%
Q1 24
-6.5%
7.4%
Net Margin
ALHC
ALHC
JBTM
JBTM
Q4 25
-1.1%
5.3%
Q3 25
0.4%
6.6%
Q2 25
1.5%
0.4%
Q1 25
-1.0%
-20.3%
Q4 24
-4.4%
-1.5%
Q3 24
-3.8%
8.6%
Q2 24
-3.5%
7.6%
Q1 24
-7.4%
5.8%
EPS (diluted)
ALHC
ALHC
JBTM
JBTM
Q4 25
$-0.04
$1.04
Q3 25
$0.02
$1.26
Q2 25
$0.07
$0.07
Q1 25
$-0.05
$-3.35
Q4 24
$-0.15
$-0.22
Q3 24
$-0.14
$1.21
Q2 24
$-0.13
$0.95
Q1 24
$-0.25
$0.71

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
JBTM
JBTM
Cash + ST InvestmentsLiquidity on hand
$604.2M
$167.9M
Total DebtLower is stronger
$323.2M
$1.5B
Stockholders' EquityBook value
$179.3M
$4.5B
Total Assets
$1.1B
$8.2B
Debt / EquityLower = less leverage
1.80×
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
JBTM
JBTM
Q4 25
$604.2M
$167.9M
Q3 25
$644.1M
Q2 25
$503.8M
Q1 25
$479.5M
Q4 24
$470.6M
$1.2B
Q3 24
$381.0M
Q2 24
$363.7M
Q1 24
$301.7M
Total Debt
ALHC
ALHC
JBTM
JBTM
Q4 25
$323.2M
$1.5B
Q3 25
$322.7M
$1.5B
Q2 25
$322.3M
$1.5B
Q1 25
$321.9M
$2.0B
Q4 24
$321.4M
$1.3B
Q3 24
$212.0M
$648.3M
Q2 24
$211.7M
$647.7M
Q1 24
$162.0M
$647.0M
Stockholders' Equity
ALHC
ALHC
JBTM
JBTM
Q4 25
$179.3M
$4.5B
Q3 25
$161.9M
$4.4B
Q2 25
$141.0M
$4.4B
Q1 25
$108.1M
$4.1B
Q4 24
$99.9M
$1.5B
Q3 24
$114.5M
$1.6B
Q2 24
$123.7M
$1.5B
Q1 24
$130.9M
$1.5B
Total Assets
ALHC
ALHC
JBTM
JBTM
Q4 25
$1.1B
$8.2B
Q3 25
$1.1B
$8.2B
Q2 25
$1.0B
$8.3B
Q1 25
$895.6M
$8.0B
Q4 24
$782.1M
$3.4B
Q3 24
$692.3M
$2.8B
Q2 24
$716.3M
$2.7B
Q1 24
$633.2M
$2.7B
Debt / Equity
ALHC
ALHC
JBTM
JBTM
Q4 25
1.80×
0.33×
Q3 25
1.99×
0.34×
Q2 25
2.29×
0.35×
Q1 25
2.98×
0.48×
Q4 24
3.22×
0.81×
Q3 24
1.85×
0.41×
Q2 24
1.71×
0.43×
Q1 24
1.24×
0.43×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
JBTM
JBTM
Operating Cash FlowLast quarter
$-50.4M
$117.4M
Free Cash FlowOCF − Capex
$-55.4M
$83.5M
FCF MarginFCF / Revenue
-5.5%
8.3%
Capex IntensityCapex / Revenue
0.5%
3.4%
Cash ConversionOCF / Net Profit
2.21×
TTM Free Cash FlowTrailing 4 quarters
$113.1M
$238.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
JBTM
JBTM
Q4 25
$-50.4M
$117.4M
Q3 25
$144.6M
$87.7M
Q2 25
$29.1M
$102.2M
Q1 25
$16.6M
$34.4M
Q4 24
$-8.7M
$128.7M
Q3 24
$26.2M
$71.9M
Q2 24
$23.5M
$21.6M
Q1 24
$-6.2M
$10.4M
Free Cash Flow
ALHC
ALHC
JBTM
JBTM
Q4 25
$-55.4M
$83.5M
Q3 25
$139.1M
$56.5M
Q2 25
$21.1M
$83.7M
Q1 25
$8.4M
$14.4M
Q4 24
$-18.0M
$118.7M
Q3 24
$16.9M
$65.0M
Q2 24
$11.8M
$11.1M
Q1 24
$-17.4M
$-100.0K
FCF Margin
ALHC
ALHC
JBTM
JBTM
Q4 25
-5.5%
8.3%
Q3 25
14.0%
5.6%
Q2 25
2.1%
9.0%
Q1 25
0.9%
1.7%
Q4 24
-2.6%
25.4%
Q3 24
2.4%
14.3%
Q2 24
1.7%
2.8%
Q1 24
-2.8%
-0.0%
Capex Intensity
ALHC
ALHC
JBTM
JBTM
Q4 25
0.5%
3.4%
Q3 25
0.6%
3.1%
Q2 25
0.8%
2.0%
Q1 25
0.9%
2.3%
Q4 24
1.3%
2.1%
Q3 24
1.3%
1.5%
Q2 24
1.7%
2.6%
Q1 24
1.8%
2.7%
Cash Conversion
ALHC
ALHC
JBTM
JBTM
Q4 25
2.21×
Q3 25
38.77×
1.33×
Q2 25
1.86×
30.06×
Q1 25
Q4 24
Q3 24
1.85×
Q2 24
0.70×
Q1 24
0.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons